Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Medium Chain Acyl CoA Dehydrogenase Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Not applicableLooking for participantsNCT07734090
What this trial is testing

Natural History of MADD

Who this might be right for
Multiple Acyl-CoA Dehydrogenase Deficiency
Icahn School of Medicine at Mount Sinai 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05933200
What this trial is testing

Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Ultragenyx Pharmaceutical Inc 69
Not applicableLooking for participantsNCT06623032
What this trial is testing

Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals

Who this might be right for
Medium-chain Acyl-CoA Dehydrogenase Deficiency
University of Copenhagen 30
Not applicableStudy completedNCT02517307
What this trial is testing

Fatty Acid Oxidation Defects and Insulin Sensitivity

Who this might be right for
Very Long-chain Acyl-CoA Dehydrogenase DeficiencyTrifunctional Protein DeficiencyLong-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency+3 more
Oregon Health and Science University 41
Not applicableNo Longer AvailableNCT01461304
What this trial is testing

Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism

Who this might be right for
Very Long-chain acylCoA Dehydrogenase (VLCAD) DeficiencyCarnitine Palmitoyltransferase Deficiencies (CPT1, CPT2)Mitochondrial Trifunctional Protein Deficiency+5 more
Jerry Vockley, MD, PhD
Testing effectiveness (Phase 2)Study completedNCT01886378
What this trial is testing

UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)Carnitine Palmitoyltransferase (CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency+2 more
Ultragenyx Pharmaceutical Inc 29